Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Implementing Germ Defence digital behaviour change intervention via all primary care practices in England to reduce respiratory infections during the COVID-19 pandemic: an efficient cluster randomised controlled trial using the OpenSAFELY platform.

Ainsworth B. et al, (2023)

Insights from Large-Scale Analysis of Long Term and Repeat Antibiotic Prescribing Pre and during the COVID-19 Pandemic Periods

Orlek A. et al, (2023)

New UK clinical trials legislation will prioritise transparency

Devito NJ. and Goldacre B., (2023), BMJ

OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide, and methotrexate monitoring, and factors associated with change in monitoring rate

The OpenSAFELY Collaborative None. et al, (2023)

The impact of lidocaine plaster prescribing reduction strategies: a comparison of two national health services in Europe

Mattsson M. et al, (2023)

The impact of lidocaine plaster prescribing reduction strategies: a comparison of two national health services in Europe

Mattsson M. et al, (2023)

The impact of lidocaine plaster prescribing reduction strategies: A comparison of two national health services in Europe

Mattsson M. et al, (2023), British Journal of Clinical Pharmacology

The impact of Long COVID on Health-Related Quality-of-Life using OpenPROMPT

Carlile O. et al, (2023)

The impact of the COVID-19 pandemic on Antipsychotic Prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: A federated analysis of 59 million patients’ primary care records in situ using OpenSAFELY

The OpenSAFELY Collaborative: None. et al, (2023)

The Impact of the COVID-19 Pandemic on Anti-Psychotic Prescribing in Individuals with Autism, Dementia, Learning Disability, Serious Mental Illness or Living in a Care Home: A Federated Analysis of 59 Million Patients’ Primary Care Records in Situ Using OpenSAFELY

Macdonald O. et al, (2023)

Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY.

Green ACA. et al, (2023), BMJ Med, 2

Weight trends amongst adults with diabetes or hypertension during the COVID-19 pandemic: an observational study using OpenSAFELY

Samuel M. et al, (2023)

Identifying Patterns of Clinical Interest in Clinicians' Treatment Preferences: Hypothesis-free Data Science Approach to Prioritizing Prescribing Outliers for Clinical Review.

MacKenna B. et al, (2022), JMIR Med Inform, 10

Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised patients on kidney replacement therapy: observational cohort study using the OpenSAFELY-UKRR linked platform and SRR database

Zheng B. et al, (2022)

Association between household composition and severe COVID-19 outcomes in older people by ethnicity: an observational cohort study using the OpenSAFELY platform

Wing K. et al, (2022), International Journal of Epidemiology, 51, 1745 - 1760

Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY

Green A. et al, (2022), BMC Medicine, 20

Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELY

Russell MD. et al, (2022), The Lancet Rheumatology, 4, e853 - e863

Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records

Thompson EJ. et al, (2022), Nature Communications, 13

Comparative effectiveness of two- and three-dose schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study

Parker EPK. et al, (2022)

Data-Driven Identification of Unusual Prescribing Behavior: Analysis and Use of an Interactive Data Tool Using 6 Months of Primary Care Data From 6500 Practices in England (Preprint)

Hopcroft LEM. et al, (2022)

Load More

1
2
3
4
5
6
7
...
»